These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 702282)

  • 1. Pharmacokinetics of drug permeation through human skin.
    Chandrasekaran SK; Bayne W; Shaw JE
    J Pharm Sci; 1978 Oct; 67(10):1370-4. PubMed ID: 702282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Humidity on In Vitro Human Skin Permeation Experiments for Predicting In Vivo Permeability.
    Ishida M; Takeuchi H; Endo H; Yamaguchi JI
    J Pharm Sci; 2015 Dec; 104(12):4223-4231. PubMed ID: 26461468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What happens in the skin? Integrating skin permeation kinetics into studies of developmental and reproductive toxicity following topical exposure.
    Dancik Y; Bigliardi PL; Bigliardi-Qi M
    Reprod Toxicol; 2015 Dec; 58():252-81. PubMed ID: 26475253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.
    Yamamoto S; Karashima M; Sano N; Fukushi C; Tohyama K; Arai Y; Hirabayashi H; Amano N
    Pharm Res; 2017 Nov; 34(11):2415-2424. PubMed ID: 28828717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of skin penetration.
    Cooper ER
    J Pharm Sci; 1976 Sep; 65(9):1396-7. PubMed ID: 966163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of transdermal drug delivery.
    Berner B
    J Pharm Sci; 1985 Jul; 74(7):718-21. PubMed ID: 3928870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models.
    Liu X; Anissimov YG; Grice JE; Cheruvu HS; Ghosh P; Raney SG; Maibach HI; Roberts MS
    J Control Release; 2021 Jun; 334():37-51. PubMed ID: 33857564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous penetration of drugs applied in transdermal delivery systems: an in vivo based approach for evaluating computer generated penetration models.
    Keurentjes AJ; Maibach HI
    Regul Toxicol Pharmacol; 2019 Nov; 108():104428. PubMed ID: 31326435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finite dose pharmacokinetics of skin penetration.
    Cooper ER; Berner B
    J Pharm Sci; 1985 Oct; 74(10):1100-2. PubMed ID: 4078710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear free energy relationship analysis of permeability across polydimethylsiloxane (PDMS) membranes and comparison with human skin permeation in vitro.
    Liu X; Zhang K; Abraham MH
    Eur J Pharm Sci; 2018 Oct; 123():524-530. PubMed ID: 30107227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the percutaneous absorption of drugs.
    Chandrasekaran SK; Shaw JE
    Curr Probl Dermatol; 1978; 7():142-55. PubMed ID: 752450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.